Le Lézard
Classified in: Health
Subjects: CCA, FVT

Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference


ST. LOUIS, Jan. 2, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 3:00 p.m. Pacific Standard Time (6:00 p.m. Eastern Standard Time). 

The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts' website at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen to the broadcast and free downloads of these players are available at the broadcast site. The broadcast will remain available on the Investor Relations section of Express Scripts' website for 90 days.

About Express Scripts

Express Scripts puts medicine within reach by practicing pharmacy smarter ? taking bold actions, delivering specialized care, creating innovative solutions, and leveraging data insights ? to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services.  Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

 

SOURCE Express Scripts Holding Company


These press releases may also interest you

at 21:27
Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae Enters into Agreement with Labcorp for Sale of Business
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
/C O R R E C T I O N -- Valcare Medical/
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

at 19:59
Genomma Lab Internacional Announces Results for the First Quarter 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 19:46
South Florida City Launches Groundbreaking Initiative to Reduce Gun Violence and Foster Peace
Although gun violence is down by 12%, gun-related homicide is up by 44%. Therefore, the City of Lauderhill is announcing a pivotal strategy to reduce gun violence and promote peace among its 75,000 residents. This plan highlights Lauderhill's...

More news about Health...


News published on and distributed by: